{"id":95991,"title":"Nanosynth Group PLC (AIM:NNN) Response to shareholder enquiries","publisher":"Share Talk","author":"sharetalk","published":"2022-04-22T06:29:01+00:00","modified":"2022-04-22T06:29:01+00:00","canonical_url":"https://www.share-talk.com/nanosynth-group-plc-aimnnn-response-to-shareholder-enquiries/","markdown_url":"https://www.share-talk.com/nanosynth-group-plc-aimnnn-response-to-shareholder-enquiries.md","json_url":"https://www.share-talk.com/nanosynth-group-plc-aimnnn-response-to-shareholder-enquiries.json","category":"Technology, Media & Telecoms","categories":["Technology, Media & Telecoms"],"tags":["anti-pathogenic","core","nanosynth group","NNN","Nottingham","Nottingham Trent University","Pharm 2 Farm","TECHNOLOGY","Virosynth"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"**nanosynth group plc**, the AIM quoted company, notes the recent enquiries from its shareholders and wishes to confirm that as stated in the announcement on 10 February 2022.\n\nThe Company intends to grow by acquisition. The Board continues to progress this strategy and, at the appropriate time, a further announcement will be made.\n\nENQUIRIES :\n\n**nanosynth group plc**\n\n**Mark Duffin (Chief Executive Officer)**\n\n**via IFC Advisory**"}